(MSGS) Madison Square Garden Sports - Ratings and Ratios
Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US55825T1034
MSGS: Basketball, Hockey, Esports, Sports Teams, Performance Centers
Madison Square Garden Sports Corp. (NYSE: MSGS) is a leading professional sports organization with a storied history in American athletics. At its core, the company owns and operates two of the most iconic franchises in U.S. sports: the New York Knicks of the NBA and the New York Rangers of the NHL. These teams are not just competitive powerhouses but also lucrative financial assets, given their massive followings and prime market positioning in New York City.
Beyond its flagship franchises, MSGS extends its reach through a network of developmental teams, including the Hartford Wolf Pack (AHL) and the Westchester Knicks (NBA G League). These affiliates serve as talent pipelines for the Knicks and Rangers, ensuring a steady flow of young, skilled players. Additionally, the company has made a strategic foray into the burgeoning esports industry through Knicks Gaming, which competes in the NBA 2K League. This move reflects the companys effort to diversify its revenue streams and engage with younger, digitally-native audiences.
MSGS also operates state-of-the-art training facilities, such as the Madison Square Garden Training Center in Greenburgh, New York. These facilities not only enhance player performance but also host events and activities that drive additional revenue. The companys infrastructure is designed to maximize the value of its sports assets while maintaining a strong operational foundation.
From a financial perspective, MSGS is a company with a market capitalization of approximately $5.05 billion, reflecting its significant presence in the sports and entertainment industry. Its P/E ratio of 89.14 indicates a premium valuation, likely driven by the strong brand equity of its franchises and growth potential in new media and esports. The forward P/E of 1250.00 suggests that investors are pricing in substantial future growth, though this also raises questions about whether the company can meet such high expectations.
With a P/B ratio of 1.57 and a P/S ratio of 4.87, MSGS appears to be trading at a moderate premium relative to its book value and revenue. This could be attributed to the intangible value of its sports franchises, which often command high multiples due to their monopoly-like status in their respective markets. The companys ability to monetize its assets through ticket sales, sponsorships, media rights, and merchandise will be key to justifying
Additional Sources for MSGS Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
MSGS Stock Overview
Market Cap in USD | 5,082m |
Sector | Communication Services |
Industry | Entertainment |
GiC Sub-Industry | Movies & Entertainment |
IPO / Inception | 2015-10-01 |
MSGS Stock Ratings
Growth 5y | 36.9% |
Fundamental | 31.8% |
Dividend | 1.0% |
Rel. Strength Industry | -18.2 |
Analysts | 4.17/5 |
Fair Price Momentum | 162.19 USD |
Fair Price DCF | 63.75 USD |
MSGS Dividends
Dividend Yield 12m | 0.00% |
Yield on Cost 5y | % |
Annual Growth 5y | -100.00% |
Payout Consistency | 1.0% |
MSGS Growth Ratios
Growth Correlation 3m | -87.3% |
Growth Correlation 12m | 87.1% |
Growth Correlation 5y | 69% |
CAGR 5y | -0.32% |
CAGR/Max DD 5y | -0.01 |
Sharpe Ratio 12m | 0.17 |
Alpha | -10.71 |
Beta | 0.80 |
Volatility | 24.14% |
Current Volume | 103k |
Average Volume 20d | 113.2k |
As of February 23, 2025, the stock is trading at USD 203.11 with a total of 102,957 shares traded.
Over the past week, the price has changed by -4.04%, over one month by -7.57%, over three months by -11.11% and over the past year by +8.15%.
Neither. Based on ValueRay Fundamental Analyses, Madison Square Garden Sports is currently (February 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 31.78 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of MSGS as of February 2025 is 162.19. This means that MSGS is currently overvalued and has a potential downside of -20.15%.
Madison Square Garden Sports has received a consensus analysts rating of 4.17. Therefor, it is recommend to buy MSGS.
- Strong Buy: 3
- Buy: 1
- Hold: 2
- Sell: 0
- Strong Sell: 0
According to ValueRays Forecast Model, MSGS Madison Square Garden Sports will be worth about 192.9 in February 2026. The stock is currently trading at 203.11. This means that the stock has a potential downside of -5.02%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 259.8 | 27.9% |
Analysts Target Price | 264.8 | 30.4% |
ValueRay Target Price | 192.9 | -5% |